Immediate Impact
3 from Science/Nature 69 standout
Citing Papers
mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Lu‐En Wai being referenced
273 Phase i study of LioCyx-M, autologous hepatitis B virus (HBV)-specific T cell receptor (TCR) T-cells, in recurrent HBV-related hepatocellular carcinoma (HCC) post-liver transplantation
2020
Rapamycin, But Not Cyclosporine or FK506, Alters Natural Killer Cell Function
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lu‐En Wai | 74 | 108 | 32 | 36 | 13 | 181 | |
| Jessica Voss | 66 | 185 | 29 | 45 | 8 | 270 | |
| Daniela Caravelli | 125 | 77 | 19 | 41 | 13 | 203 | |
| Simone Dertschnig | 56 | 182 | 33 | 43 | 11 | 273 | |
| Sarah Thirkell | 98 | 211 | 15 | 32 | 8 | 275 | |
| Cristian G. Beccaría | 103 | 175 | 55 | 67 | 15 | 283 | |
| R. Williams | 66 | 63 | 31 | 111 | 13 | 287 | |
| Xenia Ficht | 40 | 111 | 42 | 88 | 16 | 254 | |
| Werner Frings | 69 | 111 | 10 | 48 | 10 | 206 | |
| Akshaya Ramachandran | 53 | 63 | 47 | 65 | 16 | 196 | |
| Belén Palencia | 155 | 198 | 15 | 88 | 13 | 283 |
All Works
Loading papers...